Roche

Roche and Pfizer launch pharma's first official Google+ pages
PM Live
Tue, 12/6/11 - 11:40 am
Roche
Pfizer
social media
Google+
Regeneron Drops as Eye Drug Shown Similar to Roche's Lucentis
Bloomberg Businessweek
Mon, 12/5/11 - 12:28 pm
Roche
Lucentis
Regeneron
Eyela
wet-AMD
Roche Pays $20M To Settle Whistleblower Lawsuit
Pharmalot
Fri, 12/2/11 - 11:20 am
Roche
whistleblower lawsuits
Rituxan
Medicare
Medicaid
CEO: Roche would consider more money-back deals
Fierce Pharma
Thu, 12/1/11 - 12:16 pm
Avastin
Roche
Severin Schwan
Winners and Losers of Roche's Avastin Woes
Motley Fool
Tue, 11/29/11 - 06:48 pm
Roche
Avastin
breast cancer
Merck
GSK
Bristol-Myers Squibb
Eli Lilly
Teva Pharmaceuticals
Dr Reddy's
Watson
Seattle Genetics
Joining FDA, Canada pulls Avastin's breast cancer indication
Fierce Pharma
Tue, 11/29/11 - 01:40 pm
Canada
Avastin
breast cancer
Roche
Roche, PTC strike potential $490M deal for genetic disease program
Fierce Biotech
Tue, 11/29/11 - 10:22 am
Roche
PTC Therapeutics
spinal muscular atrophy
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Pushing Onwards With CETP Inhibition: What Big-Time Drug Development Is All About
Seeking Alpha
Sun, 11/20/11 - 12:14 pm
CETP inhibitors
Merck
Roche
Eli Lilly
Anacetrapib
dalcetrapib
evacetrapib
F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
NY Times, NY
Fri, 11/18/11 - 11:51 am
FDA
Avastin
breast cancer
Roche
Genentech
No new cost-cutting, Roche chairman pledges
Fierce Pharma
Mon, 11/14/11 - 12:24 pm
Roche
Franz Humer
FDA gives priority to Roche skin cancer drug vismodegib
Pharma Times, UK
Wed, 11/9/11 - 12:07 pm
Roche
vismodegib
FDA
skin cancer
basal cell carcinoma
hedgehog pathway inhibitor
Study: Deal terms getting richer as pharmas stockpile antibody tech
Fierce Biotech
Tue, 11/8/11 - 11:06 am
antibodies
autoimmune disease
CNS
Roche
AstraZeneca
Bristol-Myers Squibb
Novartis
Pfizer
Merck
mAb
China Biotech Week In Review: Roche's China Strategy
Seeking Alpha
Sun, 11/6/11 - 12:43 pm
Roche
China National Biotechnology Group
Aslan
Alios BioPharma
ImmunoBiology Ltd
Healthgen Biotechnology
Roche Unit Didn't Follow Procedures To Prevent Drug Contamination; Galena Presents Positive NeuVax Clinical Results
Biomed Reports
Sun, 11/6/11 - 12:25 pm
Roche
Avastin
Galena Biopharma
NeuVax
breast cancer
Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill
TheStreet.com
Tue, 11/1/11 - 09:01 am
Pharmasset
hepatitis C
Ribavirin
Vertex
Abbott Laboratories
PSI-7977
JNJ
Roche
Bristol-Myers Squibb
Doctors Are Split On Avastin For Breast Cancer
Pharmalot
Thu, 10/27/11 - 11:12 am
breast cancer
physicians
Avastin
Roche
Taxol
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Seeking Alpha
Sun, 10/23/11 - 10:49 am
Roche
Anadys
hepatitis C
ANA773
Abbott Laboratories
Roche Seeks ‘Targeted Acquisitions,’ Not Abbott-Sized Deal
Bloomberg
Fri, 10/21/11 - 10:54 am
Severin Schwan
Roche
Abbott Laboratories
M&A
Pharma CEOs
Abbott May Be Doing The Right Thing At The Wrong Time
Seeking Alpha
Fri, 10/21/11 - 09:57 am
Abbott Laboratories
reorganization
Amgen
Biogen Idec
Bristol-Myers Squibb
GSK
JNJ
Boston Scientific
Medtronic
Pfizer
Roche
Pharmasset

Pages